BioSpace News Archive

Vyant Bio, Inc., an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system diseases.

Denali Therapeutics Inc. will highlight during a corporate presentation at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, at 11:15 a.m. Eastern Time.

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the National Medical Products Administration (NMPA) has approved the CoreValve™ Evolut™ PRO TAVR system for the treatment of severe aortic stenosis (AS) for symptomatic patients in China who are at high or extreme risk for open heart surgery.

Visby Medical™, a leading medical diagnostic company, today announced that it will make its debut appearance at the 40th Annual J.P. Morgan Healthcare Conference.

Conference call and webcast to take place on Tuesday, January 18, 2022, at 5:00 PM E.T.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today introduced 2022 financial guidance and commented on its outlook for the upcoming year.

Kymera Therapeutics, Inc., a biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, announced its research and development goals and key milestones for 2022.

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, outlined its recent accomplishments and expected upcoming milestones.

Vaxxinity, Inc. has announced that the company has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research for the exploration of markers for target engagement in individuals with Parkinson’s disease.

PDS Biotechnology Corporation announced that it has been granted U.S. Patent Application No. 15,724,818 titled “Novel HPV16 Non HLA-Restricted T-cell Vaccines, Composition and Methods of Use Thereof” by the United States Patent and Trademark Office.